PSP Research LLC

SEC CIK: 0002106939
Latest filing: Jul 9, 2026

SEC filings (opens in a new tab)

DNLI holding history

Denali Therapeutics Inc. in every 13F filed by PSP Research LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNLI overview All 13F holders of DNLI Full Q2 2026 holdings

Shares (Q2 2026): 8,463
Value: $217.7K
% of portfolio: 0.1%
Quarters held: 2; Since Q4 2025

Holdings of DNLI by PSP Research LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	8,463	$217.7K	0.1%	+8,463	New	Holders
Q1 2026	0	$0	0.0%	−31,762−100.0%	Sold out	Holders
Q4 2025	31,762	$524.4K	0.5%	–	No prior filing	Holders